Pandalan, Baby Girl M.

HRN: 28-69-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/15/2026
03/27/2026
IV
18mg
Q36hours
T/c Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: